Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-II)

NAActive, not recruitingINTERVENTIONAL
Enrollment

475

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

March 4, 2024

Study Completion Date

December 31, 2025

Conditions
Prostate Cancer
Interventions
RADIATION

Hypofractionated Radiosurgery

"Image-guided stereotactic Linac based RT preferable with dedicated radiosurgery system such as CyberKnife"

Trial Locations (8)

13353

Charité Berlin, Department of Radiation Oncology and Radiotherapy (CVK), Berlin

24105

Saphir Radiosurgery Center Northern Germany, Kiel

University Medical Center Schleswig-Holstein, Kiel

50937

University Medical Center Cologne, Department of Radiation Oncology, Cyberknife- and Radiotherapy, Cologne

60528

Saphir Radiosurgery Center Frankfurt am Main, Frankfurt am Main

60590

University Hospital Frankfurt, Department of Radiation Therapy and Oncology, Frankfurt am Main

81377

European Cyberknife Center Munich, Munich

99089

CyberKnife Centrum Mitteldeutschland, Erfurt

All Listed Sponsors
collaborator

University of Luebeck

OTHER

collaborator

Saphir Radiosurgery Center Northern Germany

UNKNOWN

lead

University Hospital Schleswig-Holstein

OTHER

NCT03795337 - Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-II) | Biotech Hunter | Biotech Hunter